Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy

Malignant pleural mesothelioma (MPM) is an aggressive malignancy with a severe prognosis, and with a long-standing need for more effective therapeutic approaches. However, treatment with immune checkpoint inhibitors is becoming an increasingly effective strategy for MPM patients. In this scenario, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lofiego, Maria Fortunata, Cannito, Sara, Fazio, Carolina, Piazzini, Francesca, Cutaia, Ornella, Solmonese, Laura, Marzani, Francesco, Chiarucci, Carla, Di Giacomo, Anna Maria, Calabrò, Luana, Coral, Sandra, Maio, Michele, Covre, Alessia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715476/
https://www.ncbi.nlm.nih.gov/pubmed/34968251
http://dx.doi.org/10.3390/epigenomes5040027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715476/
https://www.ncbi.nlm.nih.gov/pubmed/34968251
http://dx.doi.org/10.3390/epigenomes5040027

Ejemplares similares